Aggregated News From Investment Management Regulators

Remittance Advice – Genomics Biotech Ltd (Earlier known as Abner Pharmaceuticals Ltd) in the matter of Genomics Biotech Ltd.

IndiaSEBI IN

Report/Flag

Please complete the required fields.



This news item was originally published by the Securities and Exchange Board of India (SEBI IN). See the Remittance Advice here: Source link

Return Home

Regulator Information

Regulator Name: Securities and Exchange Board of India
Abbreviation: SEBI
Jurisdiction: India
Website: https://www.sebi.gov.in/
Email: [email protected]
More Information

Recent Articles

ASIC calls on industry to continue to improve resilience during market outages

ASIC AU 0
ASIC is calling on market operators and participants to continue to implement its expectations to improve the resilience of the Australian equity market during...
Read more

ESMA will not publish August systematic internaliser regime data for non-equity instruments other than bonds and CTP data

ESMA 0
The European Securities and Markets Authority (ESMA) will not publish the 1 August 2022 publication of the systematic internaliser (SI) regime data for non-equity...
Read more

Macroprudential decision: Recommendation on mortgage borrowers’ maximum debt-servicing burden – credit institutions’ capital requirements also reviewed

FIN-FSA FI 0
The Board of the Financial Supervisory Authority (FIN-FSA) recommends that housing loans in future be granted, as a rule, to loan applicants whose total...
Read more

ASIC wins appeal on Cigno and BHF Solutions Federal Court decision

ASIC AU 0
ASIC has succeeded in its appeal before the Full Federal Court which has found unanimously that a ‘financial supply fee’ charged by Cigno Pty...
Read more

Quarterly stakeholder bulletin

IOMFSA IM 0
Published on: 28 June 2022 The Isle of Man Financial Services Authority has issued the latest edition of its quarterly update for stakeholders.
Read more

Get the latest from Regulatory.News in your inbox!

×

© Copyright 2022 - Regulatory.News